Home LiteratureArticle Details
PMID: 18662966 Published · ppublish English Comment Editorial

Follicular lymphoma, survival, and rituximab: is it time to declare victory?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 26 ·No. 28 ·2008-10-01 ·Pages 4537-8

Horning SJ

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents/therapeutic use Clinical Trials as Topic Humans Lymphoma, Follicular/drug therapy,mortality Rituximab Survival Rate
Chemicals
Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Rituximab
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Horning Sandra J
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
1527-7755
DOI
10.1200/JCO.2008.16.1398
Published
2008-10-01
Epub
2008-00-28
Pages
4537-8
Language
English
Region
United States
NLM ID
8309333
Subset
IM
Corrections
CommentOn
PMID: 18662969
External Links
PubMed source DOI: 10.1200/JCO.2008.16.1398 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2